Global Aptamers Market Size, Share, Growth Analysis, By Type(Nucleic Acid and Peptide), By Application(Diagnostics, Therapeutics) - Industry Forecast 2024-2031

Global Aptamers Market size was valued at USD 1.20 billion in 2022 and is poised to grow from USD 1.43 billion in 2023 to USD 5.83 billion by 2031, at a CAGR of 19.2% during the forecast period (2024-2031).

Many researchers are interested in aptamers because of their competitive advantages in recent developments in the production, purification, and drug delivery for killing target cells. Small molecular size, low immunogenicity, low manufacturing costs, and less side effects compared to antibodies are a few of the benefits; these factors may encourage the development of innovative aptamers, leading to market expansion.

Due to several genetic variations, there are presently no extremely effective therapies for infections, despite extensive attempts. The SELEX technology-based diagnostic kits and assays have the capacity to produce high-affinity neutralizers. As a result, it is anticipated that the release of diagnostic kits on the market will spur market expansion. Aptamer is a second-generation diagnostic kit for healthcare that was created utilising DNA aptamer-based technology.

It is inexpensive, chemically synthesised, and a growing diagnostic kit. Soma Logic stated in March 2022 that it had begun employing the SomaScan Assay to analyse 210 million protein measurements from 30,000 samples for the European Prospective Investigation into Cancer and Nutrition (EPIC) research. Through a deeper understanding of the disease, researchers will be better able to forecast cancer, which will help the market flourish by meeting the growing demand.

Due to their tiny size, high specificity, selectivity, and efficacy, diagnostic solutions based on aptamers are the preferred option among diagnostic and pathology labs for the diagnosis of disease at the cellular level. Around 27.5 million individuals are anticipated to receive a cancer diagnosis by the year 2040, according to predictions from Cancer Research UK.

US Aptamers Market is poised to grow at a sustainable CAGR for the next forecast year.